Fadraciclib, CAS 1070790-89-4

Product Description: Fadraciclib (CYC065) is a second-generation, orally available ATP-competitive inhibitor of CDK2/CDK9 kinases[1] with IC50s of 5 and 26 nM, respectively[2].

Applications: Cancer-Kinase/protease

Formula: C21H31N7O

References: [1]Cocco E, et al. Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo. Br J Cancer. 2016 Jul 26;115(3):303-11./[2]Sumana Devata, et al. Molecular markers and venous thromboembolism (VTE) in acute myelogenous leukemia (AML)

CAS Number: 1070790-89-4

Molecular Weight: 397.52

Compound Purity: 99.78

Research Area: Cancer

Solubility: DMSO : ≥ 100 mg/mL

Target: CDK

• SKU: MEXHY-101212-10.1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-101212-10.1
• Package Unit: 10 mM/1 ml
• Quantity Unit: STK